Shihping Hsu

Dr. Shihping Hsu

Far Eastern Memorial Hospital Taiwan, Banchiao, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2014 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
HCHung-Yuan Chen
Hung-Yuan Chen
YCYen-Ling Chiu
Yen-Ling Chiu
YCYi-Fang Chuang
Yi-Fang Chuang
SHShihping Hsu
Shihping Hsu
MPMei-Fen Pai
Mei-Fen Pai
YPYu-Sen Peng
Yu-Sen Peng
The visceral adiposity index (VAI) is a newly-derived measure of visceral adiposity with well-validated predictive power for cardiovascular (CV) outcomes in the general population. However, this predictability has not been investigated in hemodialysis patients, and whether VAI is superior to waist circumference (WC) and waist-to-height ratio (WHtR) in predicting CV outcomes and survival in hemodialysis patients remains unknown. We performed a prospective study including 464 prevalent hemodialysis patients. The composite outcome was the occurrence of death and CV events during follow-up. Using multivariate Cox regression analysis, VAI, WC and WHtR were tested for the predictive power of outcomes. To evaluate the predictive performance of the VAI, WC and WHtR, time-dependent receiver operating characteristic curve (ROC) analysis was performed. VAI, WC and WHtR positively correlated with each other. Patients with a higher VAI (tertile 3 vs. tertile 1, adjusted hazard ratio (HR), 1.65; 95% confidence interval (CI), 1.12-2.42; tertile 2 vs. tertile 1, adjusted HR, 1.52; 95% CI, 1.1-2.18) had more composite outcomes. VAI had a similar predictive power of all-cause mortality to WC and WHtR, but superior predictive power of composite and CV outcomes to WC when analyzed by a stepwise forward likelihood ratio test. In time-dependent ROC analysis, VAI, WC and WHtR showed similar predictive performance for outcomes. VAI is an optimal method to measure visceral adiposity to assess long-term CV outcomes and all-cause mortality in prevalent hemodialysis patients. VAI may provide a superior predictive power of CV outcomes to WC and WHtR. ClinicalTrials.gov NCT01457625

18 December 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
HCHao-Hsiang Chang
Hao-Hsiang Chang
SHShihping Hsu
Shihping Hsu
CCChiang Chien
Chiang Chien
To confer further therapeutic potential and prevent some adverse effects by the mesenchymal stem cells (MSCs) transplantation, we explored the effects of locally intrarenal arterial administration of hypoxic preconditioned MSCs in the anti-Thy1.1 induced rat glomerulonephritis. Proteinuria, histochemical staining, and western blotting were used to explore the therapeutic effects and mechanisms. Locally intrarenal arterial MSCs transplantation successfully implanted the fluorescent or CD44 labeled MSCs in the nephritic glomeruli, ameliorated proteinuria, and glomerulosclerosis in nephritic rats. Hypoxic preconditioning significantly upregulated hypoxic inducible factor-1α/VEGF (HIF-1α/VEGF) in the MSCs and was more efficient than normoxic MSCs in reducing the degree of urinary protein, glomerulosclerosis, fibrosis, macrophage/monocyte infiltration, GRP78 mediated endoplasmic reticulum stress, Beclin-1/LC3-II mediated autophagy, and Bax/Bcl-2/caspase 3 mediated apoptosis. Hypoxic MSCs could further promote intranuclear nuclear factor (erythroid-derived 2, Nrf2) and reduce nuclear factor kappa B expression in nephritic kidneys. As compared to normoxic MSCs, hypoxic MSCs transplantation significantly upregulated the renal expression of anti-oxidative response elements/enzymes including glutamate-cysteine ligase catalytic subunit, glutamate-cysteine ligase modifier subunit, glutathione peroxidase, catalase, Mn, and Cu/Zn superoxide dismutase. In summary, intrarenal hypoxic preconditioning MSCs transplantation was more effective to activate hypoxic inducible factor-1α/VEGF/Nrf2 (HIF-1α/VEGF/Nrf2) signaling, preserve anti-oxidant proteins and anti-oxidative responsive element proteins, and subsequently reduce glomerular apoptosis, autophagy, and inflammation.

2 February 2009 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
DKDar-Chih Kuo
Dar-Chih Kuo
SHShihping Hsu
Shihping Hsu
CCChiang-Ting Chien
Chiang-Ting Chien
Increased reactive oxygen species (ROS) and hyperlipidemia can promote arterial thrombus. We evaluated the potential of a partially hydrolyzed guar gum (PHGG) as dietary fiber on lipid profiles and FeCl3-induced arterial thrombosis in the high fat-diet fed hamsters. Our in vitro results found that PHGG is efficient to scavenge O2 -•, H2O2, and HOCl. High fat-diet increased plasma triglyceride, total cholesterol, LDL, VLDL, methylguanidine and dityrosine level and accelerated FeCl3-induced arterial thrombosis formation (from 463 ± 51 to 303 ± 45 sec). Low dose PHGG supplement significantly decreased the total cholesterol, LDL, methylguanidine and dityrosine level and delayed the time for arterial thrombosis formation (528 ± 75 sec). High dose PHGG supplement decreased the level in triglyceride, total cholesterol, LDL and VLDL and further delayed the time for arterial thrombus (671 ± 36 sec). The increased Bax protein and decreased Bcl-2 and HSP-70 protein expression was found in the carotid and femoral arteries of high fat-diet hamsters. Low and high dose of PHGG supplement decreased Bax expression and increased Bcl-2 and HSP-70 protein expression. We found that FeCl3 significantly enhanced intercellular adhesion molecule-1 and 4-hydroxynonenal expression in the endothelial site of damaged artery after 150-sec FeCl3 stimulation. PHGG supplement decreased the endothelial ICAM-1 and 4-hydroxynonenal expression after 150-sec FeCl3 stimulation. Based on these results, we conclude that PHGG supplement can increase antioxidant protein expression and thus decrease oxidative stress induced arterial injury.

27 December 2013 in Transplantation
Verified
Journal Article
Closed access
CYChih-Ching Yang
Chih-Ching Yang
KCKuo-Hsin Chen
Kuo-Hsin Chen
SHShihping Hsu
Shihping Hsu
CCChiang Chien
Chiang Chien
Background We elucidated the protective mechanism of increased prostacyclin (PGI2) derived from adenoviral cyclo-oxygenase (COX)-1/prostacyclin synthase (PGIS) (Adv-COPI) gene transfer in rat kidneys with ischemia-reperfusion (I/R) injury. Methods We tended to augment PGI2 production by intrarenal arterial Adv-COPI administration with renal venous clamping in female Wistar rats. After Adv-COPI transfection, we evaluated the renal COX-1 and PGIS protein expression and PGI2 and prostaglandin E2 (PGE2) levels in the kidney and renal venous plasma. We evaluated the protective effect of PGI2 on hypoxia/reoxygenation-induced tubular cells injury or I/R kidneys by measuring oxidative stress, necrosis, apoptosis, and autophagy in tubules and kidneys and determining renal function, microcirculation, and accumulation of tubular 4-hydroxynonenal in the kidney in vivo. Results Adv-COPI treatment selectively augmented COX-1 and PGIS protein expression in the renal proximal and distal tubules and significantly increased PGI2, not PGE2, production in the renal venous plasma and kidney at the baseline level. I/R markedly depressed renal blood flow and increased the production in O2-., PGE2, the expression in P47 and Rac-1 expression of two nicotinamide adenine dinucleotide phosphate oxidase subunits, cytosolic cytochrome C release, proapoptotic marker lamin expression, the pathologic appearance of necrosis, apoptosis, and autophagy, and blood urea nitrogen and creatinine levels in the damaged kidneys. Adv-COPI protected distal and proximal tubules against hypoxia/reoxygenation-enhanced oxidative stress and autophagic, apoptotic, and necrotic cell death. Adv-COPI significantly improved renal function by restoring renal blood flow, reducing nicotinamide adenine dinucleotide phosphate oxidase–derived and mitochondria-derived oxidative stress, and necrosis, apoptosis, and autophagy. Conclusions Increased PGI2 by Adv-COPI protects the kidney against I/R-induced oxidative stress, necrosis, apoptosis and autophagy.

1 January 2021 in Renal Failure
Verified
Journal Article
Open access
WTWan-Chuan Tsai
Wan-Chuan Tsai
HWHon-Yen Wu
Hon-Yen Wu
YCYen-Ling Chiu
Yen-Ling Chiu
JYJu-Yeh Yang
Ju-Yeh Yang
MPMei-Fen Pai
Mei-Fen Pai
YPYu-Sen Peng
Yu-Sen Peng
Long-term dietary phosphorus excess influences disturbances in mineral metabolism, but it is unclear how rapidly the mineral metabolism responds to short-term dietary change in dialysis populations...

10 July 2025 in Renal Failure
Verified
Journal Article
Open access
SHShihping Hsu
Shihping Hsu
CCChiang-Ting Chien
Chiang-Ting Chien
Renal recovery after acute kidney injury (AKI) significantly improves outcomes. This cohort study explored the efficacy of six urinary biomarkers and the spot urine creatinine-to-osmolality ratio (sUCr/Osm) in predicting renal recovery 3 months after in-hospital AKI. Data from the Assessment, Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury study, involving 744 patients with in-hospital AKI, were analyzed. The urinary biomarker with the highest area under the receiver operating characteristic curve (AUC) was selected as the representative for comparison. Renal recovery was defined as an absolute increase of <26.5 μmol/L or a relative elevation of <20% from the baseline serum creatinine (SCr) level at three months postdiagnosis. Among the 744 patients, 85.6% achieved renal recovery. Uromodulin demonstrated a greater AUC of 0.580 (95% CI: 0.518-0.641) than the other five biomarkers did. With a cutoff of 1,360 ng/mL, uromodulin sensitivity was 0.774 (95% CI: 0.741-0.806). The sUCr/Osm test exhibited high sensitivity (0.881; 95% CI: 0.856-0.906) with a cutoff of 8.84 (sUCr/Osm8.84) and high specificity (0.785; 95% CI: 0.707-0.863) with a cutoff of 21.22 (sUCr/Osm21.22). The positive predictive values of the three methods were approximately 0.880. The performance of these tests in predicting renal recovery based on both criteria in 298 patients with chronic kidney disease was also comparable. Urinary biomarkers, especially uromodulin, and the sUCr/Osm test may be effective in predicting renal recovery three months after in-hospital AKI. The sUCr/Osm test may offer a more accessible approach for routine use, with sUCr/Osm8.84 demonstrating high sensitivity for screening and sUCr/Osm21.22 exhibiting high specificity for further discrimination.